Literature DB >> 12114814

Characterization of Pheochromocytomas in a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis Gene Nf1.

Arthur S. Tischler, T. Shane Shih, Bart O. Williams, Tyler Jacks.   

Abstract

Patients with neurofibromatosis type 1 (NF1) show an increased frequency of pheochromocytomas. The NF1 gene encodes a GTPase-activating protein that controls the activity of ras proteins in intracellular signaling. A mouse strain with a knockout mutation of Nf1, the murine counterpart of NF1, has recently been constructed. This mutation, designated Nf1(n31), has been shown to be associated with the frequent development of pheochromocytomas in heterozygous animals. Pheochromocytomas are extremely rare in wild-type mice. We have characterized the tumors to assess their relevance as a model for human pheochromocytomas. The frequency of pheochromocytomas was determined in inbred compared to outbred mice carrying the Nf1(31) mutation. Paraffin sections of pheochromocytomas from seven mice were stained immunohistochemically for the catecholamine biosynthetic enzymes, tyrosine hydroxylase (TH), and phenylethanolamine-N-methyltransferase (PNMT) to infer their profiles of catecholamine synthesis, and for chromogranin A (CGA) to infer their content of secretory granules. Cultured cells from a representative tumor were studied in vitro to assess proliferation and neuronal differentiation. Pheochromocytomas arose in approx 15% of Nf1(n31) mice with a mixed genetic background, but were absent in inbred mice. Approximately one-fourth of the tumors were bilateral. The tumors exhibited variable morphology. All included cells that appeared well differentiated and resembled normal chromaffin cells in that they expressed TH, PNMT, and CGA. Focal neuronal differentiation was also observed. In cell culture, the tumor cells ceased to proliferate and the majority underwent terminal differentiation into TH-positive cells with neuronal morphology. The phenotype of pheochromocytomas in mice with the Nf1(31) mutation resembles that of human pheochromocytomas, particularly with respect to their ability to produce epinephrine, as inferred from positive staining for PNMT. The tumors also resemble both normal and neoplastic human adrenal medulla with respect to their extensive differentiation into neuron-like cells in vitro. This change in phenotype may be related to ras activation. These neoplasms may be valuable both as models for the pathobiology of adrenal medullary neoplasia, and as a source of epinephrine-producing pheochromocytoma cell lines, for which adequate models currently do not exist.

Entities:  

Year:  1995        PMID: 12114814     DOI: 10.1007/bf02738732

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  45 in total

1.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes.

Authors:  M B BORNSTEIN
Journal:  Lab Invest       Date:  1958 Mar-Apr       Impact factor: 5.662

2.  Pheochromocytoma; its relationship to the neurocutaneous syndromes.

Authors:  A S GLUSHIEN; M M MANSUY; D S LITTMAN
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

3.  Adrenal chromaffin cells as multipotential neurons for autografts.

Authors:  N K Mahanthappa; F H Gage; P H Patterson
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

4.  Multiple mitogenic signalling pathways in chromaffin cells: a model for cell cycle regulation in the nervous system.

Authors:  A S Tischler; J C Riseberg; V Cherington
Journal:  Neurosci Lett       Date:  1994-02-28       Impact factor: 3.046

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Nerve growth factor is a mitogen for cultured chromaffin cells.

Authors:  L E Lillien; P Claude
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

7.  Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice.

Authors:  C Suri; B P Fung; A S Tischler; D M Chikaraishi
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

8.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.

Authors:  A S Tischler; R Freund; J Carroll; A L Cahill; R L Perlman; J Alroy; J C Riseberg
Journal:  Lab Invest       Date:  1993-05       Impact factor: 5.662

10.  Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences.

Authors:  B O Williams; E M Schmitt; L Remington; R T Bronson; D M Albert; R A Weinberg; T Jacks
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  13 in total

1.  Nicotine stimulates expression of the PNMT gene through a novel promoter sequence.

Authors:  Marian J Evinger; Elizabeth Mathew; Stefan Cikos; James F Powers; Ying-Shuan E Lee; Sabina Sheikh; Robert A Ross; Arthur S Tischler
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 2.  Review: the role of neural crest cells in the endocrine system.

Authors:  Meghan Sara Adams; Marianne Bronner-Fraser
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 3.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.

Authors:  Thomas J Turbyville; Demirkan B Gürsel; Robert G Tuskan; Jessica C Walrath; Claudia A Lipschultz; Stephen J Lockett; David F Wiemer; John A Beutler; Karlyne M Reilly
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

5.  Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.

Authors:  Jessica J Hawes; Robert G Tuskan; Karlyne M Reilly
Journal:  Neurogenetics       Date:  2007-01-11       Impact factor: 2.660

Review 6.  Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Authors:  Nicole M Brossier; Steven L Carroll
Journal:  Brain Res Bull       Date:  2011-08-10       Impact factor: 4.077

7.  C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.

Authors:  C L Smith-Hicks; K C Sizer; J F Powers; A S Tischler; F Costantini
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

8.  MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice.

Authors:  Shoichiro Ohta; Edwin W Lai; John C Morris; Douglas A Bakan; Brenda Klaunberg; Susannah Cleary; James F Powers; Arthur S Tischler; Mones Abu-Asab; Daniel Schimel; Karel Pacak
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

Review 9.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

Review 10.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.